<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">Liver metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is the major cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> related <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>To identify and characterize proteins associated with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, we have compared the conditioned serum-free medium of highly metastatic KM12SM <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells with the parental, poorly metastatic, KM12C cells using quantitative SILAC analyses on a linear ion trap-Orbitrap Velos mass spectrometer </plain></SENT>
<SENT sid="2" pm="."><plain>In total, 1337 proteins were simultaneously identified in SILAC forward and reverse experiments </plain></SENT>
<SENT sid="3" pm="."><plain>For quantification, 1098 proteins were selected in both experiments, with 155 proteins showing &gt;1.5 fold-change </plain></SENT>
<SENT sid="4" pm="."><plain>About 52% of these proteins were secreted directly or using alternative secretion pathways </plain></SENT>
<SENT sid="5" pm="."><plain>GDF15, S100A8/A9 and SERPINI1 showed capacity to discriminate <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> serum samples from healthy controls using ELISA assays </plain></SENT>
<SENT sid="6" pm="."><plain>In silico analyses of deregulated proteins in the secretome of metastatic cells showed a major abundance of proteins involved in cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, migration and invasion </plain></SENT>
<SENT sid="7" pm="."><plain>To characterize the tumorigenic and metastatic properties of some top up- and down-regulated proteins we used siRNA silencing and antibody blocking </plain></SENT>
<SENT sid="8" pm="."><plain>Knocking-down expression of NEO1, SERPINI1 and PODXL showed a significant effect on cellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Silencing or blocking experiments with SOSTDC1, CTSS, EFNA3, CD137L/TNFSF9, ZG16B and MDK caused a significant decrease in migration and invasion of highly metastatic cells </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, silencing of SOSTDC1, EFNA3 and CD137L/TNFSF9 reduced liver colonization capacity of KM12SM cells </plain></SENT>
<SENT sid="11" pm="."><plain>Finally, the panel of six proteins involved in invasion showed association to poor prognosis and overall survival after dataset analysis of gene alterations </plain></SENT>
<SENT sid="12" pm="."><plain>In summary, we have defined a collection of proteins that are relevant to understand the mechanisms underlying <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, migration, invasion and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>